Haemonetics Corp (NYSE:HAE)

69.99
Delayed Data
As of Feb 23
 +0.74 / +1.07%
Today’s Change
37.20
Today|||52-Week Range
72.33
+20.51%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 56.00, with a high estimate of 75.00 and a low estimate of 50.00. The median estimate represents a -19.99% decrease from the last price of 69.99.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Haemonetics Corp. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.44
Sales
$227.8M
Reporting Date
Feb 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.23%
 
 
 
 
 
 
Growthannually 22.06%
 
 
 
 
 
 

Sales

Growthquarterly 1.06%
 
 
 
 
 
 
Growthannually 1.34%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.